DISC-0974
A Phase 1b/2a Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DISC-0974 in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
What's the purpose of the trial?
Accepting patients
![](https://maps.googleapis.com/maps/api/staticmap?key=AIzaSyDXH19UJTDtS-I9fdYHjFXupEiuQkBgRPk&size=520x280&scale=1&maptype=raodmap&markers=icon%3Ahttps%3A%2F%2Fassets.sparkcures.com%2Fimg%2Fmaps%2Fhospital-default.png%7C30.2628%2C-81.441299%7C42.282101%2C-83.727303%7C44.022499%2C-92.466698%7C38.638401%2C-90.263397%7C40.764198%2C-73.956703%7C36.0896%2C-80.2686%7C41.502998%2C-81.623703%7C45.498901%2C-122.670998%7C39.9478%2C-75.192497%7C29.707199%2C-95.396698%7C47.62652%2C-122.32956%7C43.060799%2C-88.028397%7C41.0574%2C-74.069603%7C40.6395%2C-74.584%7C40.809601%2C-73.293404%7C40.370701%2C-74.147301%7C40.701202%2C-73.593452%7C41.028%2C-73.733704)
Participating Centers
There are 18 centers participating in this trial. Enter a location below to find the closest center.
Experimental Treatments
Learn more about the experimental treatments being evaluated in this clinical trial.
- DISC-0974 is a monoclonal antibody that may help to increase iron levels in patients with certain blood disorders and cancers.
Arms / Cohorts
Explore eligibility, treatments and learn more about potential cohorts.
Accepting patients
Accepting patients
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.